5th Workshop on the Characterization of Heparin Products

Overview

An informal workshop intended to encourage open discussion and debate on the physico-chemical and functional characterization of therapeutic products derived from heparin, and to explore possible clinical and regulatory implications as seen from different viewpoints. Symposium organized by the National Institute for Biological Standards and Control, the European Directorate for the Quality of Medicines and Healthcare (Council of Europe), and The United States Pharmacopeial Convention.

Topics Include:

  • Unfractionated Heparin (UFH): Characterization and Standardization
  • UFH Active Pharmaceutical Ingredient (API) Sourcing and Production
  • UFH Pharmacopeial Monograph Revision Updates
  • Implementation of New and Revised Monograph Methods—Lessons Learned and Practical Hints
  • Low Molecular Weight Heparins (LMWH)
  • New Pharmacopeial Methods, Manufacturing Process Controls, and Characterizations
  • All Heparin Products  
  • Regulatory and Dossier Requirements

Preliminary Agenda

When: August 14–15, 2012
Where: USP Headquarters, Meetings Center, Rockville, MD

Registration Fees & Information

Register Online Now!

  • Registration Fee: $350.00

Registration fee includes full two-day program; meeting materials; continental breakfast and lunch each day and a networking reception.

Who Should Participate:

  • Heparin API and Heparin Product Manufacturers
  • LMWH Manufacturers
  • Test Kit Manufacturers
  • Heparin Suppliers
  • Regulators
  • Standards-setting Organizations
  • Compendial Bodies
  • Academia

For additional information, email us at conferences@usp.org or call +1-301-816-8136.